Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars

Overview

Journal Front Pharmacol

Date 2020 Oct 26

PMID 33101027

Citations 1

Authors

Valeria Conti

Graziamaria Corbi

Teresa Iannaccone

Bianca Corrado

Luigi Giugliano

Serena Lembo

Amelia Filippelli

Maurizio Guida

Affiliations

Soon will be listed here.

Abstract

Background: The prevention or early treatment of pathological scars is the most appropriate therapeutic approach. Gels and patches containing onion extract and allantoin are safe and effective in patients with scars of various origins and severity. However, no controlled studies have evaluated the effects of the patch formulation in women after Cesarean delivery. This study aimed to investigate the effects of a patch containing Allium cepa and allantoin on Cesarean section (C-section) scars.

Methods: This is an observational study. Women were consecutively recruited at the University Hospital of Salerno and subdivided into two groups considering the number of C-section. Group A included subjects without and group B with a history of C-section. Scars assessment was made using digital photographs and the Patient and Observer Scar Assessment Scale (POSAS). After 4 weeks, the C-section of the women who had applied a patch containing Allium cepa and allantoin and those of women who had not used any products (controls) were re-evaluated as at baseline. The Observers independently performed the scars assessment at baseline and after 4 weeks. Data are expressed as the difference of the POSAS scores after 4 weeks minus the POSAS scores at baseline. The statistical significance was established at a p value <0.05.

Results: Ninety-three subjects completed the study (47 in group A and 46 in group B). Women who had used a patch showed an improvement in total score by observer scale when compared with controls (p = 0.013). By the patient scale, no significant changes from baseline were found in group A and group B. Group B with patch showed changes in scars' pigmentation (p = 0.015), relief (p = 0.039), and pliability (p = 0.046) in comparison of controls. Digital photographs confirmed such improvements in women who had already undergone previous C-section, while no significant changes from baseline were found in women without a history of C-section.

Conclusions: Intense treatment of just 4 weeks with a patch containing Alium Cepa extract and allantoin was able to improve pigmentation, relief, and pliability of C-section scars in women with a history of C-section.

Clinical Trial Registration: ClinicalTrials.gov, identifier NCT04046783.

Citing Articles

Controlling Inflammation Pre-Emptively or at the Time of Cutaneous Injury Optimises Outcome of Skin Scarring.

Ud-Din S, Bayat A Front Immunol. 2022; 13:883239.

PMID: 35711461 PMC: 9197255. DOI: 10.3389/fimmu.2022.883239.

References

Guertler A, Schwaiger H, Poetschke J, Steckmeier S, Gauglitz G . Objective evaluation of an occlusive overnight intensive patch containing onion extract and allantoin for hypertrophic scars. J Cosmet Dermatol. 2020; 19(9):2415-2420. DOI: 10.1111/jocd.13561. View

Sidgwick G, McGeorge D, Bayat A . A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring. Arch Dermatol Res. 2015; 307(6):461-77. PMC: 4506744. DOI: 10.1007/s00403-015-1572-0. View

Ramos F, Takaishi Y, Shirotori M, Kawaguchi Y, Tsuchiya K, Shibata H . Antibacterial and antioxidant activities of quercetin oxidation products from yellow onion (Allium cepa) skin. J Agric Food Chem. 2009; 54(10):3551-7. DOI: 10.1021/jf060251c. View

Willital G, Heine H . Efficacy of Contractubex gel in the treatment of fresh scars after thoracic surgery in children and adolescents. Int J Clin Pharmacol Res. 1994; 14(5-6):193-202. View

Ho W, Ying S, Chan P, Chan H . Use of onion extract, heparin, allantoin gel in prevention of scarring in chinese patients having laser removal of tattoos: a prospective randomized controlled trial. Dermatol Surg. 2006; 32(7):891-6. DOI: 10.1111/j.1524-4725.2006.32192.x. View

Gauglitz G, Korting H, Pavicic T, Ruzicka T, Jeschke M . Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2010; 17(1-2):113-25. PMC: 3022978. DOI: 10.2119/molmed.2009.00153. View

Tansey M, Appleton J . Inhibition of fungal growth by garlic extract. Mycologia. 1975; 67(2):409-13. View

Manca M, Matricardi P, Cencetti C, Peris J, Melis V, Carbone C . Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery. Int J Pharm. 2016; 505(1-2):204-11. DOI: 10.1016/j.ijpharm.2016.04.008. View

Fang Q, Chen C, Zhang M, Huang C, Wang X, Xu J . The Effectiveness of Topical Anti-scarring Agents and a Novel Combined Process on Cutaneous Scar Management. Curr Pharm Des. 2016; 23(15):2268-2275. DOI: 10.2174/1381612822666161025144434. View

10.

Draelos Z, Baumann L, Fleischer Jr A, Plaum S, Avakian E, Hardas B . A new proprietary onion extract gel improves the appearance of new scars: a randomized, controlled, blinded-investigator study. J Clin Aesthet Dermatol. 2012; 5(6):18-24. PMC: 3390235. View

11.

Willital G, Simon J . Efficacy of early initiation of a gel containing extractum cepae, heparin, and allantoin for scar treatment: an observational, noninterventional study of daily practice. J Drugs Dermatol. 2013; 12(1):38-42. View

12.

Araujo L, Grabe-Guimaraes A, Mosqueira V, Carneiro C, Silva-Barcellos N . Profile of wound healing process induced by allantoin. Acta Cir Bras. 2010; 25(5):460-6. DOI: 10.1590/s0102-86502010000500014. View

13.

Selamoglu Z, Dusgun C, Akgul H, Gulhan M . Antioxidant Activities of the Ethanolic Extracts of Some Contained-Allantoin Plants. Iran J Pharm Res. 2018; 16(Suppl):92-98. PMC: 5963650. View

14.

Mehta M, Branford O, Rolfe K . The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring. Burns Trauma. 2016; 4:15. PMC: 4964041. DOI: 10.1186/s41038-016-0040-1. View

15.

Gold M, McGuire M, Mustoe T, Pusic A, Sachdev M, Waibel J . Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg. 2014; 40(8):825-31. DOI: 10.1111/dsu.0000000000000050. View

16.

Hashemzaei M, Delarami Far A, Yari A, Entezari Heravi R, Tabrizian K, Taghdisi S . Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017; 38(2):819-828. PMC: 5561933. DOI: 10.3892/or.2017.5766. View

17.

Campanati A, Savelli A, Sandroni L, Marconi B, Giuliano A, Giuliodori K . Effect of allium cepa-allantoin-pentaglycan gel on skin hypertrophic scars: clinical and video-capillaroscopic results of an open-label, controlled, nonrandomized clinical trial. Dermatol Surg. 2010; 36(9):1439-44. DOI: 10.1111/j.1524-4725.2010.01654.x. View

18.

Corbi G, Conti V, Davinelli S, Scapagnini G, Filippelli A, Ferrara N . Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?. Front Pharmacol. 2016; 7:364. PMC: 5062465. DOI: 10.3389/fphar.2016.00364. View

19.

Draaijers L, Tempelman F, Botman Y, Tuinebreijer W, Middelkoop E, Kreis R . The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004; 113(7):1960-5. DOI: 10.1097/01.prs.0000122207.28773.56. View

20.

Idriss N, Maibach H . Scar assessment scales: a dermatologic overview. Skin Res Technol. 2009; 15(1):1-5. DOI: 10.1111/j.1600-0846.2008.00327.x. View